As used in the Theodore R. Montoya Memorial Hemophilia Program Act:

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

A. “blood products” means certain components or factors obtained from whole blood which when periodically administered to persons suffering from hemophilia result in relief or control of the disease;

B. “eligible patient” means a person suffering from hemophilia whose case has been evaluated and accepted for provision of services by the hemophilia program established by the school;

C. “fund” means the hemophilia fund;

D. “hemophilia” means a genetic disease in which uncontrolled bleeding from otherwise minor causes may result in death or disability;

E. “hemophilia program” means the New Mexico comprehensive hemophilia diagnostic and treatment program established by the school to provide comprehensive clinical evaluation of patients suffering from hemophilia, out-patient blood product usage, counseling services to families of persons suffering from hemophilia and outreach to the public;

F. “provider” means any blood service or laboratory furnishing blood products to the school and its program administration for eligible patients;

G. “university” means the university of New Mexico; and

H. “secretary” means the secretary of health and environment [secretary of health].